Bank of Montreal
CRBP icon

Bank of Montreal’s Corbus Pharmaceuticals CRBP Stock Holding History

Bank of Montreal’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-833
Closed -$189K – 4686
2018
Q3 		$189K Buy
+833
New +$135K ﹤0.01% 2785

Other funds holding CRBP

EMG
ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Bank of Montreal's CRBP Position: Q3 2021 in Review

Bank of Montreal sold out of Corbus Pharmaceuticals (CRBP) in Q3 2021, closing a stake of 598 shares — an estimated $33K sold.

Bank of Montreal first reported a position in CRBP in Q3 2015 and held it in 16 quarters. The position peaked at $619K in Q2 2019. 85 funds tracked by Wall St. Rank hold CRBP as of Q3 2021.

  • Bank of Montreal reported no remaining Corbus Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Bank of Montreal sold 598 Corbus Pharmaceuticals shares in Q3 2021, an estimated $33K.
  • Bank of Montreal first reported a position in Corbus Pharmaceuticals in Q3 2015 and held it in 16 quarters.
  • Bank of Montreal's Corbus Pharmaceuticals position peaked at $619K in Q2 2019.
  • 85 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q3 2021.

Based on Bank of Montreal's 13F filing for Q3 2021, filed 12 Nov 2021.